$0.952
+0.002 (+0.23%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
VRXA 相似圖表分析預測
Alphio's VRXA stock price prediction model matches the current Veraxa Biotech AG tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.95 (+0.11%). The 1-week path is $0.95 (-0.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Veraxa Biotech AG 股票嗎?
Veraxa Biotech AG (VRXA) appears to be a good buy right now due to its recent positive news and potential for recovery. The stock has shown a 5.10% increase over the last five days, indicating a short-term upward trend. Additionally, the projected final change based on historical patterns is +93.44%, suggesting significant upside potential. However, the stock has a high risk, as it has declined 93.98% year-to-date, and its current price is only $1.03, which is near its 52-week low of $0.95. This high volatility and risk should be considered by investors.
VRXA 股價於 Thursday 收在 $0.95,此前上漲 +0.23%
Veraxa Biotech AG (VRXA) last closed at $0.9522, gaining +0.23%. These facts feed the 1-day and 1-week VRXA price prediction above.
預測驅動因素
Veraxa Biotech AG(VRXA)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 VRXA 最接近的股票,依相似度排序。
VRXA 季節性分析
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。